Estrogen status and heredity are major determinants of premenopausal bone mass.
about
Association of multiple nucleotide variations in the pituitary glutaminyl cyclase gene (QPCT) with low radial BMD in adult womenEffect of altered reproductive function and lowered testosterone levels on bone density in male endurance athletes.The effects of phthalates on the ovaryLower bone mineral content in hypertensive compared with normotensive overweight Latino children and adolescents.The assessment of osteoporosis risk factors in Iranian women compared with Indian women.Prediction of changes in bone mineral density in postmenopausal women treated with once-weekly bisphosphonates.Poor sleep quality and later sleep timing are risk factors for osteopenia and sarcopenia in middle-aged men and women: The NEO study.The genetics of osteoporosis: 'complexities and difficulties'.High prevalence of low vitamin D and musculoskeletal complaints in women with breast cancer.Velocities of bone mineral accrual in black and white American children.Di(2-ethylhexyl) phthalate inhibits antral follicle growth, induces atresia, and inhibits steroid hormone production in cultured mouse antral follicles.Genistein exposure inhibits growth and alters steroidogenesis in adult mouse antral follicles.Equol inhibits growth, induces atresia, and inhibits steroidogenesis of mouse antral follicles in vitro.Effects of polymorphisms of the sex hormone-binding globulin (SHBG) gene on free estradiol and bone mineral density.Premenopausal women with a distal radial fracture have deteriorated trabecular bone density and morphology compared with controls without a fractureSex steroids, bone turnover and bone mineral density in pre-, peri-, and postmenopausal women.Sex steroids, bone mass, and bone loss. A prospective study of pre-, peri-, and postmenopausal women.The Val432Leu polymorphism of the CYP1B1 gene is associated with differences in estrogen metabolism and bone density.A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis.Maternal Mineral and Bone Metabolism During Pregnancy, Lactation, and Post-Weaning Recovery.Estrogen status and bone mass in the premenopausal period: is osteoporosis a developmental disease?Osteoporosis and oral bone loss.Alveolar bone height and postcranial bone mineral density: negative effects of cigarette smoking and parity.Effect of central precocious puberty and gonadotropin-releasing hormone analogue treatment on peak bone mass and final height in females.
P2860
Q28269880-D62F32F5-04CA-4A84-81EF-CD771C3F33EFQ28294563-46F1700D-E056-410D-9C7C-CD6AFC3A991BQ28387140-EB122C66-50C5-495A-9A0C-F500DF79514BQ33270787-95678B14-6F6F-4EE5-A8C3-F3B5F67DBA55Q33321446-B13E4D08-FFFB-461E-BA9F-51127B76078EQ33569806-2E2967CC-E024-4EB6-AEC8-7EE121A3B19EQ33620834-89F0272B-B580-476D-8FB0-91BDD86C269AQ33899983-E567DDE3-9B39-4CE0-8590-A8980D23044EQ34024686-93DE7CB0-EDD1-43CF-90B8-CA0962E07E9EQ35157817-A9E8657D-F918-40E9-91E8-A0C16D2E5169Q35217745-F0CDDB72-7E60-4E31-ADED-59DC7B3CB1ADQ36552391-0AF0A127-AA84-4072-A08C-4E6972A620B9Q36655771-DA71CB1E-A645-40A8-85B4-17FE3D6062D8Q36947048-4CD2676E-ED26-4762-9B86-7A5BD6FF8F31Q37109419-CD6DA744-A717-43ED-9472-5ABD4C39DB48Q37296034-D8C39956-6F02-41CF-991C-F28EDDD68A5DQ37350836-FD573443-D8D3-4680-9EE2-C11C0FF0C0CBQ37665507-D5F807EF-4894-4942-8572-8FB24A7036ADQ37995500-495D2776-5359-414A-BF23-B7AE290EF7A8Q38737740-1C39FC29-B00E-41C8-8E87-6F344C007F3FQ40734258-B3650350-1DE8-4020-8729-F433A8532A17Q41691690-761B1E14-B6B8-430A-A835-02536DBB7C68Q47236012-2AAFD031-3120-428B-BB56-2B0C6314CB20Q47287444-D88900D7-6F88-4B50-91DB-A0EA28E9907C
P2860
Estrogen status and heredity are major determinants of premenopausal bone mass.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Estrogen status and heredity are major determinants of premenopausal bone mass.
@ast
Estrogen status and heredity are major determinants of premenopausal bone mass.
@en
type
label
Estrogen status and heredity are major determinants of premenopausal bone mass.
@ast
Estrogen status and heredity are major determinants of premenopausal bone mass.
@en
prefLabel
Estrogen status and heredity are major determinants of premenopausal bone mass.
@ast
Estrogen status and heredity are major determinants of premenopausal bone mass.
@en
P2093
P2860
P356
P1476
Estrogen status and heredity are major determinants of premenopausal bone mass.
@en
P2093
Armamento-Villareal R
Civitelli R
Villareal DT
P2860
P304
P356
10.1172/JCI116138
P407
P577
1992-12-01T00:00:00Z